Sun Pharma gets Brazil nod for Semaglutide
Sun Pharmaceutical Industries has received Brazilian Health Regulatory Agency ANVISA approval to manufacture and market semaglutide injection in the Latin American country. The generic drugmaker plans to launch the product in the next few days in partnership with Hypera Pharma, a pharmaceutical company in Brazil. It will be available as a pre‑filled, multi‑dose injectable pen…